TreeWAS – Variant ID: rs7581919

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N80.9 Endometriosis, unspecified	0.026	0.974	0.000
N80.0 Endometriosis of uterus	0.024	0.976	0.000
N80 Endometriosis	0.023	0.977	0.000
F03 Unspecified dementia	0.000	0.978	0.022
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.021	0.979	0.000
N80.2 Endometriosis of Fallopian tube	0.020	0.980	0.000
G40.9 Epilepsy, unspecified	0.020	0.980	0.000
G40 Epilepsy	0.020	0.980	0.000
N80.4 Endometriosis of rectovaginal septum and vagina	0.019	0.981	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.000	0.983	0.017
N80.6 Endometriosis in cutaneous scar	0.017	0.983	0.000
H65.3 Chronic mucoid otitis media	0.000	0.983	0.017
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.000	0.983	0.017
N80.3 Endometriosis of pelvic peritoneum	0.016	0.984	0.000
F06.7 Mild cognitive disorder	0.000	0.984	0.016
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters	0.016	0.984	0.000
N80.5 Endometriosis of intestine	0.016	0.984	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.015	0.985	0.000
G40.8 Other epilepsy	0.015	0.985	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.015	0.985	0.000
N80.8 Other endometriosis	0.015	0.985	0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.015	0.985	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.015	0.985	0.000
F02 Dementia in other diseases classified elsewhere	0.000	0.985	0.015
G40.5 Special epileptic syndromes	0.014	0.985	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.014	0.986	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.000	0.987	0.013
F01 Vascular dementia	0.000	0.987	0.013
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.000	0.987	0.013
F02.8 Dementia in other specified diseases classified elsewhere	0.000	0.987	0.013
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.000	0.987	0.012
F06.3 Organic mood [affective] disorders	0.000	0.987	0.012
F06.2 Organic delusional [schizophrenia-like] disorder	0.000	0.988	0.012
F09 Unspecified organic or symptomatic mental disorder	0.000	0.988	0.012
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.012	0.988	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.000	0.988	0.012
F06.5 Organic dissociative disorder	0.000	0.988	0.012
F06.4 Organic anxiety disorder	0.000	0.988	0.012
F06.1 Organic catatonic disorder	0.000	0.988	0.012
F06.0 Organic hallucinosis	0.000	0.988	0.012
F00 Dementia in Alzheimer's disease	0.000	0.989	0.011
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.000	0.989	0.011
F02.3 Dementia in Parkinson's disease	0.000	0.989	0.011
F02.0 Dementia in Pick's disease	0.000	0.989	0.011
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.000	0.989	0.011
F02.2 Dementia in Huntington's disease	0.000	0.989	0.011
F02.1 Dementia in Creutzfeldt-Jakob disease	0.000	0.989	0.011
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract	0.000	0.989	0.011
F01.9 Vascular dementia, unspecified	0.000	0.989	0.011
F05 Delirium, not induced by alcohol and other psychoactive substances	0.000	0.989	0.010
F07.0 Organic personality disorder	0.000	0.990	0.010
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.000	0.990	0.010
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.000	0.990	0.010
F07.1 Postencephalitic syndrome	0.000	0.990	0.010
F01.8 Other vascular dementia	0.000	0.990	0.010
F01.3 Mixed cortical and subcortical vascular dementia	0.000	0.990	0.010
F01.2 Subcortical vascular dementia	0.000	0.990	0.010
F01.0 Vascular dementia of acute onset	0.000	0.990	0.010
F07.2 Postconcussional syndrome	0.000	0.990	0.010
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.010	0.990	0.000
F01.1 Multi-infarct dementia	0.000	0.991	0.009
T43.0 Tricyclic and tetracyclic antidepressants	0.009	0.991	0.000
N80.1 Endometriosis of ovary	0.009	0.991	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.009	0.991	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.009	0.991	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.000	0.991	0.008
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.009	0.991	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.000	0.992	0.008
T43.5 Other and unspecified antipsychotics and neuroleptics	0.008	0.992	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.008	0.992	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.992	0.008
C90.0 Multiple myeloma	0.000	0.992	0.008
F05.9 Delirium, unspecified	0.000	0.992	0.008
F05.1 Delirium superimposed on dementia	0.000	0.992	0.008
T43.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.992	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.008	0.992	0.000
T43.6 Psychostimulants with abuse potential	0.008	0.992	0.000
T43.2 Other and unspecified antidepressants	0.008	0.992	0.000
T45.0 Antiallergic and antiemetic drugs	0.007	0.992	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.000	0.992	0.007
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.007	0.993	0.000
T39.0 Salicylates	0.007	0.993	0.000
T51.0 Ethanol	0.007	0.993	0.000
T39.1 4-Aminophenol derivatives	0.007	0.993	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.007	0.993	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.007	0.993	0.000
F05.8 Other delirium	0.000	0.993	0.007
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.007	0.993	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.007	0.993	0.000
F05.0 Delirium not superimposed on dementia, so described	0.000	0.993	0.007
T43.9 Psychotropic drug, unspecified	0.007	0.993	0.000
T45.2 Vitamins, not elsewhere classified	0.007	0.993	0.000
T39.4 Antirheumatics, not elsewhere classified	0.007	0.993	0.000
T39.2 Pyrazolone derivatives	0.007	0.993	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.007	0.993	0.000
J34.2 Deviated nasal septum	0.000	0.993	0.007
O42.9 Premature rupture of membranes, unspecified	0.000	0.993	0.007
I35.1 Aortic (valve) insufficiency	0.007	0.993	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.006	0.993	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.006	0.994	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.006	0.994	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.006	0.994	0.000
T45.4 Iron and its compounds	0.006	0.994	0.000
T50.4 Drugs affecting uric acid metabolism	0.006	0.994	0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.006	0.994	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.006	0.994	0.000
T45.8 Other primarily systemic and haematological agents	0.006	0.994	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.006	0.994	0.000
T45.6 Fibrinolysis-affecting drugs	0.006	0.994	0.000
T45.3 Enzymes, not elsewhere classified	0.006	0.994	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
T50.8 Diagnostic agents	0.006	0.994	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.006	0.994	0.000
T50.1 Loop [high-ceiling] diuretics	0.006	0.994	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.006	0.994	0.000
T42.0 Hydantoin derivatives	0.006	0.994	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.006	0.994	0.000
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum	0.000	0.994	0.006
R93.8 Abnormal findings on diagnostic imaging of other specified body structures	0.000	0.994	0.006
T50.7 Analeptics and opioid receptor antagonists	0.006	0.994	0.000
T50.5 Appetite depressants	0.006	0.994	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.006	0.994	0.000
T50.0 Mineralocorticoids and their antagonists	0.006	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
R93 Abnormal findings on diagnostic imaging of other body structures	0.000	0.994	0.006
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.006	0.994	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.006	0.994	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.006	0.994	0.000
T42.3 Barbiturates	0.006	0.994	0.000
N42.9 Disorder of prostate, unspecified	0.006	0.994	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.994	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.005	0.994	0.000
H65 Nonsuppurative otitis media	0.000	0.994	0.006
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.995	0.000
T42.1 Iminostilbenes	0.005	0.995	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.005	0.995	0.000
T42.2 Succinimides and oxazolidinediones	0.005	0.995	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.005	0.995	0.000
T37.5 Antiviral drugs	0.005	0.995	0.000
T37.4 Anthelminthics	0.005	0.995	0.000
T37.3 Other antiprotozoal drugs	0.005	0.995	0.000
T37.1 Antimycobacterial drugs	0.005	0.995	0.000
T37.0 Sulphonamides	0.005	0.995	0.000
T41.2 Other and unspecified general anaesthetics	0.005	0.995	0.000
T45.5 Anticoagulants	0.005	0.995	0.000
T51 Toxic effect of alcohol	0.005	0.995	0.000
T36 Poisoning by systemic antibiotics	0.005	0.995	0.000
T49.9 Topical agent, unspecified	0.005	0.995	0.000
T49.8 Other topical agents	0.005	0.995	0.000
T49.7 Dental drugs, topically applied	0.005	0.995	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.005	0.995	0.000
T49.5 Ophthalmological drugs and preparations	0.005	0.995	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.005	0.995	0.000
T49.3 Emollients, demulcents and protectants	0.005	0.995	0.000
T49.2 Local astringents and local detergents	0.005	0.995	0.000
T49.1 Antipruritics	0.005	0.995	0.000
T40.5 Cocaine	0.005	0.995	0.000
T41.5 Therapeutic gases	0.005	0.995	0.000
T41.4 Anaesthetic, unspecified	0.005	0.995	0.000
T41.3 Local anaesthetics	0.005	0.995	0.000
T41.1 Intravenous anaesthetics	0.005	0.995	0.000
T41.0 Inhaled anaesthetics	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
T47.0 Histamine H(2)-receptor antagonists	0.005	0.995	0.000
T40.3 Methadone	0.005	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
T47.7 Emetics	0.005	0.995	0.000
T47.6 Antidiarrhoeal drugs	0.005	0.995	0.000
T47.5 Digestants	0.005	0.995	0.000
T47.3 Saline and osmotic laxatives	0.005	0.995	0.000
H91.9 Hearing loss, unspecified	0.005	0.995	0.000
T40.1 Heroin	0.005	0.995	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.005	0.995	0.000
T40.8 Lysergide [LSD]	0.005	0.995	0.000
T40.7 Cannabis (derivatives)	0.005	0.995	0.000
T40.0 Opium	0.005	0.995	0.000
T40.4 Other synthetic narcotics	0.005	0.995	0.000
T47.2 Stimulant laxatives	0.005	0.995	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.005	0.995	0.000
T48.4 Expectorants	0.005	0.995	0.000
T48.3 Antitussives	0.005	0.995	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.005	0.995	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.005	0.995	0.000
T48.0 Oxytocic drugs	0.005	0.995	0.000
R93.6 Abnormal findings on diagnostic imaging of limbs	0.000	0.995	0.005
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T47.4 Other laxatives	0.004	0.995	0.000
T48.5 Anti-common-cold drugs	0.004	0.995	0.000
T38.9 Other and unspecified hormone antagonists	0.004	0.995	0.000
T38.7 Androgens and anabolic congeners	0.004	0.995	0.000
T38.4 Oral contraceptives	0.004	0.995	0.000
T38.2 Antithyroid drugs	0.004	0.995	0.000
T38.0 Glucocorticoids and synthetic analogues	0.004	0.995	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.995	0.000
T38.5 Other oestrogens and progestogens	0.004	0.995	0.000
T38.1 Thyroid hormones and substitutes	0.004	0.995	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.995	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.995	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.995	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.995	0.000
T46.7 Peripheral vasodilators	0.004	0.995	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.004	0.995	0.000
T51.9 Alcohol, unspecified	0.004	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.995	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.995	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.995	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.995	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.004	0.995	0.000
T44.0 Anticholinesterase agents	0.004	0.995	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.995	0.005
T40.2 Other opioids	0.004	0.995	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified	0.000	0.996	0.004
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.004	0.996	0.000
I51.7 Cardiomegaly	0.000	0.996	0.004
H65.1 Other acute nonsuppurative otitis media	0.000	0.996	0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
G40-G47 Episodic and paroxysmal disorders	0.004	0.996	0.000
H65.4 Other chronic nonsuppurative otitis media	0.000	0.996	0.004
H65.0 Acute serous otitis media	0.000	0.996	0.004
T40.6 Other and unspecified narcotics	0.004	0.996	0.000
J69.0 Pneumonitis due to food and vomit	0.000	0.996	0.004
Chapter VI Diseases of the nervous system	0.004	0.996	0.000
H50.9 Strabismus, unspecified	0.004	0.996	0.000
T51.8 Other alcohols	0.004	0.996	0.000
T51.3 Fusel oil	0.004	0.996	0.000
T51.2 2-Propanol	0.004	0.996	0.000
T51.1 Methanol	0.004	0.996	0.000
G82.1 Spastic paraplegia	0.004	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
T36.6 Rifamycins	0.004	0.996	0.000
T36.5 Aminoglycosides	0.004	0.996	0.000
T36.2 Chloramphenicol group	0.004	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.004	0.996	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.004	0.996	0.000
T36.4 Tetracyclines	0.004	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.004	0.996	0.000
C90.3 Solitary plasmacytoma	0.000	0.996	0.004
T36.8 Other systemic antibiotics	0.004	0.996	0.000
G82 Paraplegia and tetraplegia	0.004	0.996	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.004	0.996	0.000
T36.3 Macrolides	0.003	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.996	0.000
G11 Hereditary ataxia	0.004	0.996	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.004	0.996	0.000
G70-G73 Diseases of myoneural junction and muscle	0.004	0.996	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.996	0.004
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.996	0.003
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.004	0.996	0.000
C90.1 Plasma cell leukaemia	0.000	0.996	0.003
G31.9 Degenerative disease of nervous system, unspecified	0.004	0.996	0.000
G70 Myasthenia gravis and other myoneural disorders	0.003	0.996	0.000
T42.4 Benzodiazepines	0.003	0.996	0.000
G62 Other polyneuropathies	0.003	0.996	0.000
G20-G26 Extrapyramidal and movement disorders	0.003	0.996	0.000
G11.9 Hereditary ataxia, unspecified	0.003	0.997	0.000
G30-G32 Other degenerative diseases of the nervous system	0.003	0.997	0.000
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.000	0.997	0.003
T36.0 Penicillins	0.003	0.997	0.000
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation	0.000	0.997	0.003
G82.4 Spastic tetraplegia	0.003	0.997	0.000
H65.2 Chronic serous otitis media	0.000	0.997	0.003
G10 Huntington's disease	0.003	0.997	0.000
G82.5 Tetraplegia, unspecified	0.003	0.997	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.003	0.997	0.000
G03 Meningitis due to other and unspecified causes	0.003	0.997	0.000
G24 Dystonia	0.003	0.997	0.000
G46 Vascular syndromes of brain in cerebrovascular diseases	0.003	0.997	0.000
G63 Polyneuropathy in diseases classified elsewhere	0.003	0.997	0.000
G70.0 Myasthenia gravis	0.003	0.997	0.000
G14 Postpolio syndrome	0.003	0.997	0.000
C15.4 Middle third of oesophagus	0.000	0.997	0.003
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system	0.000	0.997	0.003
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.003	0.997	0.000
G64 Other disorders of peripheral nervous system	0.003	0.997	0.000
N42 Other disorders of prostate	0.003	0.997	0.000
G11.4 Hereditary spastic paraplegia	0.003	0.997	0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
G62.9 Polyneuropathy, unspecified	0.003	0.997	0.000
G35-G37 Demyelinating diseases of the central nervous system	0.003	0.997	0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.003	0.997	0.000
G25 Other extrapyramidal and movement disorders	0.003	0.997	0.000
G24.5 Blepharospasm	0.003	0.997	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.003	0.997	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.003	0.997	0.000
G61 Inflammatory polyneuropathy	0.003	0.997	0.000
G81 Hemiplegia	0.003	0.997	0.000
G60 Hereditary and idiopathic neuropathy	0.003	0.997	0.000
G00 Bacterial meningitis, not elsewhere classified	0.003	0.997	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.003	0.997	0.000
G82.3 Flaccid tetraplegia	0.003	0.997	0.000
J34.3 Hypertrophy of nasal turbinates	0.000	0.997	0.003
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.003	0.997	0.000
G70.9 Myoneural disorder, unspecified	0.003	0.997	0.000
H91 Other hearing loss	0.003	0.997	0.000
G11.1 Early-onset cerebellar ataxia	0.003	0.997	0.000
O42 Premature rupture of membranes	0.000	0.997	0.003
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.003	0.997	0.000
G11.8 Other hereditary ataxias	0.003	0.997	0.000
G11.3 Cerebellar ataxia with defective DNA repair	0.003	0.997	0.000
G11.2 Late-onset cerebellar ataxia	0.003	0.997	0.000
G11.0 Congenital nonprogressive ataxia	0.003	0.997	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.003	0.997	0.000
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.003	0.997	0.000
G72 Other myopathies	0.003	0.997	0.000
G12 Spinal muscular atrophy and related syndromes	0.003	0.997	0.000
G21 Secondary Parkinsonism	0.003	0.997	0.000
G24.8 Other dystonia	0.003	0.997	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.003	0.997	0.000
N42.2 Atrophy of prostate	0.003	0.997	0.000
G62.0 Drug-induced polyneuropathy	0.003	0.997	0.000
G62.8 Other specified polyneuropathies	0.003	0.997	0.000
G23 Other degenerative diseases of basal ganglia	0.003	0.997	0.000
G03.9 Meningitis, unspecified	0.003	0.997	0.000
G46.4 Cerebellar stroke syndrome	0.003	0.997	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.003	0.997	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.003	0.997	0.000
G70.2 Congenital and developmental myasthenia	0.003	0.997	0.000
G70.1 Toxic myoneural disorders	0.003	0.997	0.000
G82.0 Flaccid paraplegia	0.003	0.997	0.000
G62.2 Polyneuropathy due to other toxic agents	0.003	0.997	0.000
G63.2 Diabetic polyneuropathy	0.003	0.997	0.000
G70.8 Other specified myoneural disorders	0.003	0.997	0.000
N42.0 Calculus of prostate	0.003	0.997	0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.003	0.997	0.000
G22 Parkinsonism in diseases classified elsewhere	0.003	0.997	0.000
G25.0 Essential tremor	0.003	0.997	0.000
G60.0 Hereditary motor and sensory neuropathy	0.003	0.997	0.000
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.000	0.997	0.003
S00.1 Contusion of eyelid and periocular area	0.003	0.997	0.000
G24.3 Spasmodic torticollis	0.003	0.997	0.000
G02.0 Meningitis in viral diseases classified elsewhere	0.003	0.997	0.000
G82.2 Paraplegia, unspecified	0.003	0.997	0.000
O14.9 Preeclampsia, unspecified	0.003	0.997	0.000
G30 Alzheimer's disease	0.003	0.997	0.000
G03.0 Nonpyogenic meningitis	0.003	0.997	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.000	0.997	0.003
G25.5 Other chorea	0.003	0.997	0.000
G46.3 Brain stem stroke syndrome	0.002	0.997	0.000
G71 Primary disorders of muscles	0.003	0.997	0.000
G80 Infantile cerebral palsy	0.003	0.997	0.000
J34 Other disorders of nose and nasal sinuses	0.000	0.997	0.003
G13.0 Paraneoplastic neuromyopathy and neuropathy	0.002	0.997	0.000
H91.2 Sudden idiopathic hearing loss	0.003	0.997	0.000
G03.8 Meningitis due to other specified causes	0.002	0.997	0.000
G03.2 Benign recurrent meningitis [Mollaret]	0.002	0.997	0.000
G03.1 Chronic meningitis	0.002	0.997	0.000
G04.1 Tropical spastic paraplegia	0.002	0.997	0.000
G04.0 Acute disseminated encephalitis	0.002	0.997	0.000
G24.1 Idiopathic familial dystonia	0.002	0.997	0.000
G24.0 Drug-induced dystonia	0.003	0.997	0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.002	0.997	0.000
G24.4 Idiopathic orofacial dystonia	0.002	0.997	0.000
G24.2 Idiopathic nonfamilial dystonia	0.002	0.997	0.000
G25.2 Other specified forms of tremor	0.003	0.997	0.000
G46.8 Other vascular syndromes of brain in cerebrovascular diseases	0.002	0.997	0.000
G46.6 Pure sensory lacunar syndrome	0.002	0.997	0.000
G46.5 Pure motor lacunar syndrome	0.002	0.997	0.000
G46.1 Anterior cerebral artery syndrome	0.002	0.997	0.000
G46.0 Middle cerebral artery syndrome	0.002	0.997	0.000
G61.9 Inflammatory polyneuropathy, unspecified	0.002	0.997	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.002	0.997	0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.002	0.997	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.003	0.997	0.000
G46.2 Posterior cerebral artery syndrome	0.002	0.997	0.000
G63.8 Polyneuropathy in other diseases classified elsewhere	0.002	0.997	0.000
G63.6 Polyneuropathy in other musculoskeletal disorders	0.002	0.997	0.000
G63.5 Polyneuropathy in systemic connective tissue disorders	0.002	0.997	0.000
G63.4 Polyneuropathy in nutritional deficiency	0.002	0.997	0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.002	0.997	0.000
G63.1 Polyneuropathy in neoplastic disease	0.002	0.997	0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
G00.2 Streptococcal meningitis	0.002	0.997	0.000
G61.0 Guillain-Barre syndrome	0.003	0.997	0.000
G62.1 Alcoholic polyneuropathy	0.002	0.997	0.000
G81.9 Hemiplegia, unspecified	0.003	0.997	0.000
G81.1 Spastic hemiplegia	0.002	0.997	0.000
N42.3 Dysplasia of prostate	0.002	0.997	0.000
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.003	0.997	0.000
G41 Status epilepticus	0.002	0.997	0.000
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
G02.1 Meningitis in mycoses	0.002	0.997	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.002	0.997	0.000
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere	0.002	0.997	0.000
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema	0.002	0.997	0.000
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease	0.002	0.997	0.000
G00.3 Staphylococcal meningitis	0.002	0.997	0.000
G25.9 Extrapyramidal and movement disorder, unspecified	0.002	0.997	0.000
G60.8 Other hereditary and idiopathic neuropathies	0.002	0.997	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.002	0.997	0.000
G25.4 Drug-induced chorea	0.002	0.997	0.000
G72.0 Drug-induced myopathy	0.002	0.997	0.000
G36 Other acute disseminated demyelination	0.002	0.997	0.000
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.002	0.997	0.000
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
G25.1 Drug-induced tremor	0.002	0.997	0.000
G61.1 Serum neuropathy	0.002	0.997	0.000
G81.0 Flaccid hemiplegia	0.002	0.997	0.000
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.000	0.997	0.003
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.002	0.997	0.000
G60.3 Idiopathic progressive neuropathy	0.002	0.997	0.000
G60.2 Neuropathy in association with hereditary ataxia	0.002	0.997	0.000
G60.1 Refsum's disease	0.002	0.997	0.000
T63 Toxic effect of contact with venomous animals	0.002	0.997	0.000
G00.0 Haemophilus meningitis	0.002	0.997	0.000
G21.9 Secondary Parkinsonism, unspecified	0.002	0.997	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.002	0.997	0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.000	0.997	0.002
G37 Other demyelinating diseases of central nervous system	0.002	0.997	0.000
G35 Multiple sclerosis	0.003	0.997	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.003	0.997	0.000
G00.8 Other bacterial meningitis	0.002	0.997	0.000
G21.0 Malignant neuroleptic syndrome	0.002	0.997	0.000
G73.7 Myopathy other diseases classified elsewhere	0.002	0.997	0.000
G90-G99 Other disorders of the nervous system	0.002	0.997	0.000
G06.0 Intracranial abscess and granuloma	0.002	0.998	0.000
G72.8 Other specified myopathies	0.002	0.998	0.000
H91.0 Ototoxic hearing loss	0.002	0.998	0.000
N42.1 Congestion and haemorrhage of prostate	0.002	0.998	0.000
G00.1 Pneumococcal meningitis	0.002	0.998	0.000
G72.1 Alcoholic myopathy	0.002	0.998	0.000
H69.9 Eustachian tube disorder, unspecified	0.000	0.998	0.002
T55 Toxic effect of soaps and detergents	0.002	0.998	0.000
G21.1 Other drug-induced secondary Parkinsonism	0.002	0.998	0.000
G31.0 Circumscribed brain atrophy	0.002	0.998	0.000
H91.3 Deaf mutism, not elsewhere classified	0.002	0.998	0.000
G00.9 Bacterial meningitis, unspecified	0.002	0.998	0.000
G45.9 Transient cerebral ischaemic attack, unspecified	0.002	0.998	0.000
G72.9 Myopathy, unspecified	0.002	0.998	0.000
G72.3 Periodic paralysis	0.002	0.998	0.000
G72.2 Myopathy due to other toxic agents	0.002	0.998	0.000
G73.6 Myopathy in metabolic diseases	0.002	0.998	0.000
G73.5 Myopathy in endocrine diseases	0.002	0.998	0.000
G73.4 Myopathy in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
G73.3 Myasthenic syndromes in other diseases classified elsewhere	0.002	0.998	0.000
G73.2 Other myasthenic syndromes in neoplastic disease	0.002	0.998	0.000
G73.1 Eaton-Lambert syndrome	0.002	0.998	0.000
T61 Toxic effect of noxious substances eaten as seafood	0.002	0.998	0.000
G12.9 Spinal muscular atrophy, unspecified	0.002	0.998	0.000
G12.8 Other spinal muscular atrophies and related syndromes	0.002	0.998	0.000
G12.1 Other inherited spinal muscular atrophy	0.002	0.998	0.000
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]	0.002	0.998	0.000
G21.8 Other secondary Parkinsonism	0.002	0.998	0.000
G21.4 Vascular parkinsonism	0.002	0.998	0.000
G21.3 Postencephalitic Parkinsonism	0.002	0.998	0.000
G21.2 Secondary Parkinsonism due to other external agents	0.002	0.998	0.000
G73.0 Myasthenic syndromes in endocrine diseases	0.002	0.998	0.000
G93.9 Disorder of brain, unspecified	0.002	0.998	0.000
T23 Burn and corrosion of wrist and hand	0.002	0.998	0.000
G23.8 Other specified degenerative diseases of basal ganglia	0.002	0.998	0.000
N42.8 Other specified disorders of prostate	0.002	0.998	0.000
H91.8 Other specified hearing loss	0.002	0.998	0.000
T60 Toxic effect of pesticides	0.002	0.998	0.000
T57 Toxic effect of other inorganic substances	0.002	0.998	0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.002	0.998	0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.002	0.998	0.000
G45.3 Amaurosis fugax	0.002	0.998	0.000
H91.1 Presbycusis	0.002	0.998	0.000
T52 Toxic effect of organic solvents	0.002	0.998	0.000
G45.0 Vertebro-basilar artery syndrome	0.002	0.998	0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.002	0.998	0.000
G23.9 Degenerative disease of basal ganglia, unspecified	0.002	0.998	0.000
G23.3 Multiple system atrophy, cerebellar type	0.002	0.998	0.000
G23.2 Striatonigral degeneration	0.002	0.998	0.000
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]	0.002	0.998	0.000
G23.0 Hallervorden-Spatz disease	0.002	0.998	0.000
G93 Other disorders of brain	0.002	0.998	0.000
T65 Toxic effect of other and unspecified substances	0.002	0.998	0.000
T56 Toxic effect of metals	0.002	0.998	0.000
T54 Toxic effect of corrosive substances	0.002	0.998	0.000
G25.3 Myoclonus	0.002	0.998	0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.002	0.998	0.000
G45.2 Multiple and bilateral precerebral artery syndromes	0.002	0.998	0.000
G46.7 Other lacunar syndromes	0.002	0.998	0.000
G61.8 Other inflammatory polyneuropathies	0.002	0.998	0.000
G80.2 Infantile hemiplegia	0.002	0.998	0.000
T21 Burn and corrosion of trunk	0.002	0.998	0.000
T62 Toxic effect of other noxious substances eaten as food	0.002	0.998	0.000
G30.0 Alzheimer's disease with early onset	0.002	0.998	0.000
G45.1 Carotid artery syndrome (hemispheric)	0.002	0.998	0.000
G90.2 Horner's syndrome	0.002	0.998	0.000
G44 Other headache syndromes	0.002	0.998	0.000
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
T58 Toxic effect of carbon monoxide	0.002	0.998	0.000
G31.2 Degeneration of nervous system due to alcohol	0.002	0.998	0.000
G90 Disorders of autonomic nervous system	0.002	0.998	0.000
G30.9 Alzheimer's disease, unspecified	0.002	0.998	0.000
G80.8 Other infantile cerebral palsy	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations